GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,886.00
-5.50 (-0.29%)
May 13, 2026, 5:10 PM GMT
GSK plc Revenue
GSK plc had revenue of 7.63B GBP in the quarter ending March 31, 2026, with 1.50% growth. This brings the company's revenue in the last twelve months to 32.78B, up 3.97% year-over-year. In the year 2025, GSK plc had annual revenue of 32.67B with 4.11% growth.
Revenue (ttm)
32.78B
Revenue Growth
+3.97%
P/S Ratio
2.30
Revenue / Employee
490.42K
Employees
66,841
Market Cap
75.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.67B | 1.29B | 4.11% |
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | 33.75B | 2.93B | 9.52% |
| Dec 31, 2018 | 30.82B | 635.00M | 2.10% |
| Dec 31, 2017 | 30.19B | 2.30B | 8.24% |
| Dec 31, 2016 | 27.89B | 3.97B | 16.58% |
| Dec 31, 2015 | 23.92B | 917.00M | 3.99% |
| Dec 31, 2014 | 23.01B | -3.50B | -13.20% |
| Dec 31, 2013 | 26.51B | 74.00M | 0.28% |
| Dec 31, 2012 | 26.43B | -956.00M | -3.49% |
| Dec 31, 2011 | 27.39B | -1.01B | -3.54% |
| Dec 31, 2010 | 28.39B | 24.00M | 0.08% |
| Dec 31, 2009 | 28.37B | 4.02B | 16.49% |
| Dec 31, 2008 | 24.35B | 1.64B | 7.20% |
| Dec 31, 2007 | 22.72B | -509.00M | -2.19% |
| Dec 31, 2006 | 23.23B | 1.57B | 7.23% |
| Dec 31, 2005 | 21.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Hikma Pharmaceuticals | 2.49B |
| Convatec Group | 1.81B |
| CVS Group | 692.80M |
| Genus | 672.00M |
| HUTCHMED (China) | 407.54M |
GSK plc News
- 2 days ago - GSK enters into exclusive strategic collaboration with Sino Biopharm - TheFly
- 2 days ago - GSK Partners with China National Pharmaceutical for Bepirovirsen Development - GuruFocus
- 2 days ago - GSK Launches Final GBP 0.18 Bln Tranche Of GBP 2 Bln Share Buyback - Nasdaq
- 3 days ago - GSK to team up with Sino Biopharma for China launch of hepatitis B treatment - Reuters
- 6 days ago - Halozyme announces global collaboration and license agreement with GSK - TheFly
- 6 days ago - GSK partners with Julie Bowen, Ty Burrell to raise meningitis awareness - TheFly
- 6 days ago - Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults - Business Wire
- 7 days ago - GSK price target lowered to 2,100 GBp from 2,250 GBp at Citi - TheFly